We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$61.3B
AUM Growth
+$4.17B
Cap. Flow
-$319M
Cap. Flow %
-0.52%
Top 10 Hldgs %
13.5%
Holding
3,292
New
781
Increased
896
Reduced
876
Closed
613

Top Buys

Rank Stock Value
1
FANG icon
Diamondback Energy
FANG
+$287M
2
META icon
Meta Platforms (Facebook)
META
+$276M
3
MSFT icon
Microsoft
MSFT
+$259M
4
ADBE icon
Adobe
ADBE
+$220M
5
K
Kellanova
K
+$212M

Sector Composition

Rank Sector Weight
1 Technology 9.4%
2 Consumer Discretionary 8.24%
3 Industrials 7.97%
4 Financials 7.22%
5 Healthcare 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCEL icon
2451
Vericel Corp
VCEL
$2.25B
$261K ﹤0.01%
6,173
-28,712
-82% -$1.37M
VST icon
2452
PUT
Vistra
VST
$49.4B
$261K ﹤0.01%
+2,200
New +$187K
EB
2453
DELISTED
Eventbrite
EB
$258K ﹤0.01%
94,516
-903,239
-91% -$3.44M
CLFD icon
2454
Clearfield
CLFD
$406M
$258K ﹤0.01%
+6,618
New +$257K
DHIL
2455
DELISTED
Diamond Hill
DHIL
$258K ﹤0.01%
+1,594
New +$245K
BB icon
2456
BlackBerry
BB
$5.27B
$257K ﹤0.01%
98,113
-314,852
-76% -$750K
VISN
2457
Vistance Networks Inc
VISN
$2.71B
$253K ﹤0.01%
41,481
-746,217
-95% -$2.56M
GM icon
2458
General Motors
GM
$77.2B
$253K ﹤0.01%
5,644
-3,851,901
-100% -$179M
ZNTL icon
2459
Zentalis Pharmaceuticals
ZNTL
$295M
$253K ﹤0.01%
68,662
+28,451
+71% +$103K
OFIX icon
2460
Orthofix Medical
OFIX
$414M
$252K ﹤0.01%
16,152
+6,091
+61% +$97.6K
JILL icon
2461
J. Jill
JILL
$277M
$251K ﹤0.01%
10,167
-8,573
-46% -$279K
MITK icon
2462
Mitek Systems
MITK
$832M
$251K ﹤0.01%
+28,896
New +$293K
CYTK icon
2463
CALL
Cytokinetics
CYTK
$10.7B
$248K ﹤0.01%
4,700
-196,400
-98% -$10.9M
FOUR icon
2464
PUT
Shift4
FOUR
$3.33B
$248K ﹤0.01%
+2,800
New +$212K
BE icon
2465
PUT
Bloom Energy
BE
$69.2B
$247K ﹤0.01%
23,400
-497,200
-96% -$5.9M
CELH icon
2466
Celsius Holdings
CELH
$6.85B
$247K ﹤0.01%
+7,864
New +$330K
CLOV icon
2467
Clover Health Investments
CLOV
$2.34B
$245K ﹤0.01%
+86,819
New +$199K
IBRX icon
2468
ImmunityBio
IBRX
$8.1B
$245K ﹤0.01%
65,811
-141,385
-68% -$654K
BN icon
2469
PUT
Brookfield
BN
$109B
$244K ﹤0.01%
+6,900
New +$218K
CAG icon
2470
CALL
Conagra Brands
CAG
$7.08B
$244K ﹤0.01%
+7,500
New +$230K
ANF icon
2471
Abercrombie & Fitch
ANF
$5.09B
$243K ﹤0.01%
1,738
-56,895
-97% -$8.66M
JOBY icon
2472
Joby Aviation
JOBY
$8.06B
$243K ﹤0.01%
+48,259
New +$262K
SERV
2473
Serve Robotics
SERV
$436M
$242K ﹤0.01%
+30,475
New +$263K
MATV icon
2474
Mativ Holdings
MATV
$695M
$242K ﹤0.01%
14,234
-33,643
-70% -$591K
IDYA icon
2475
IDEAYA Biosciences
IDYA
$3.54B
$241K ﹤0.01%
+7,605
New +$288K

Similar funds

Balyasny Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Balyasny Asset Management held 3,292 positions worth $61.3B, up 7.3% from $57.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Balyasny Asset Management's Q3 2024 filing shows 781 new, 896 increased, 876 reduced and 613 closed positions. Its largest new stake was Kellanova: 2,973,544 shares worth $240M. The largest sale was Apple, an estimated $538M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8.6% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Balyasny Asset Management's largest Q3 2024 buy was Kellanova: 2,973,544 shares worth $240M.
  • Balyasny Asset Management added most to Diamondback Energy in Q3 2024, an estimated $287M increase.
  • Balyasny Asset Management's biggest Q3 2024 reduction was Apple, cutting an estimated $538M.
  • Balyasny Asset Management fully exited Airbnb in Q3 2024, selling an estimated $185M.
  • Balyasny Asset Management's ten largest holdings make up 13% of its $61.3B portfolio in Q3 2024.
  • Balyasny Asset Management opened 781 new positions and closed 613 in Q3 2024.
  • Balyasny Asset Management's portfolio value rose 7.3% quarter-over-quarter to $61.3B.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.